France Veterinary Healthcare Market Introduction and Overview
According to SPER Market Research, the France Veterinary Healthcare Market is estimated to reach USD XX billion by 2033 with a CAGR of 4.31%.
The report includes an in-depth analysis of the France Veterinary Healthcare Market, including market size and trends, product mix, applications, and supplier analysis. Veterinary healthcare encompasses early disease detection and treatment, as well as medical testing done to safeguard the well-being and productivity of animals. Numerous methods are used to conduct the testing, including the use of animal biopsies, blood, urine, and stool. Numerous domestic and wild animals can be diagnosed by veterinary medicine. The spread of new animal diseases and their consequent human-to-animal transmission through animal-to-animal contact and the consumption of animal products is driving the industry's growth. The study of diagnosing, treating, and preventing illnesses in animals is known as veterinary medicine.
- January 2022: TheraVet announced that it has signed a distribution agreement with a top animal health product distributor in France for BIOCERA-VET-OSA and BIOCERA-VET-BS.
- Pawsni Glucose Control: The French company ArcaNatura SAS and Bactana Corp. have inked a distribution deal for the former's first commercial product, Pawsni Glucose Control, which has been shown in numerous placebo-controlled mouse studies to significantly lower blood markers associated with diabetes and prediabetes without producing unfavourable hypoglycemic side effects.
Market Opportunities and Challenges
One of the main factors driving the market expansion in the next years is the requirement to increase the output of farm animal products, including eggs, milk, beef, and other dairy products. Growing pet ownership and consumer concern on animal welfare and nutrition safety are expected to fuel market expansion throughout the projection period. Over the projection period, it is anticipated that the production of animal health pharmaceuticals will continue to advance technology at a steady pace, driving market growth. Moreover, it is anticipated that technological advancements in veterinary medicine would present profitable opportunities for industry participants. These developments include vaccination banks, mobile technologies for animal owners, and the introduction of effective information management systems. A strong emphasis on innovation in animal health has led to the implementation of some policies that are enhancing the chances for market expansion. One such public-private cooperation is the Innovative Medicines Initiative (IMI), which funds cooperative research to increase innovation in veterinary drugs in France.
The use of fake medications, a lack of infrastructure and finance, and the growing expense of veterinary care, however, are anticipated to impede the market's expansion. Growing costs associated with animal testing and veterinary care represent a significant obstacle to the market's potential growth in the upcoming years. It is predicted that a lack of agricultural land and rising demand for farming space will limit market expansion. Another major barriers to the veterinary healthcare market is the decline in the number of veterinarians as a result of fewer training programmes. Strict laws and guidelines are also a major obstacle. To approve a vaccination, government officials are enforcing stringent laws and guidelines. It continues to be a significant barrier for the important actors.
Market Competitive Landscape
Key players competing in the France veterinary healthcare market include: Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, Zoetis Inc. are a few of the major participants in the sector. To grow their market shares, several of these companies are utilising a variety of market methods, such as capacity expansion, product launches, partnerships, mergers, acquisitions, and collaborations.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2019-2033 |
| Base year considered | 2022 |
| Forecast period | 2023-2033 |
| Segments covered | By Product, By Animal Type
|
| Regions covered | Central Region, Northern Region, Southern Region
|
| Companies Covered | Boehringer Ingelheim International GmbH, Ceva Animal Health, Inc., Elanco, IDEXX Laboratories, Merck & Co. Inc., Vetoquinol, Zoetis Inc., Others.
|
COVID-19 Impact on France Veterinary Healthcare Market
Due to the fact that only urgent and emergency care was permitted in France as a result of the COVID-19 epidemic, the country's veterinary services suffered significantly in terms of patient loss and financial damage. Numerous veterinary professionals experienced physical and psychological ailments linked to the pandemic, seclusion, budgetary constraints, and the infection's long-term repercussions. The COVID-19 pandemic's restrictions had a negative impact on the veterinary healthcare industry, resulting in fewer diagnostic tests and treatments being administered. The market expansion for veterinary healthcare was hampered by this decrease.
Key Target Audience
- Animal Health Companies
- Animal Welfare Organizations
- Diagnostic Laboratories
- Livestock Farmers and Ranchers
- Pet Owners
- Pharmacies and Retailers
- Research Institutions and Academia
- Veterinarians and Veterinary Clinics/Hospitals
- Others
Our in-depth analysis of the France Veterinary Healthcare Market includes the following segments:
|
By Product:
|
Diagnostics
Therapeutics
|
|
By Animal Type:
|
Dogs and Cats
Horses
Poultry
Ruminants
Swine
Other Animals
|
|
Region:
|
Central Region
Northern Region
Southern Region
|
Key Topics Covered in the Report
- France Veterinary Healthcare Market Size (FY’2023-FY’2033)
- Overview of France Veterinary Healthcare Market
- Segmentation of France Veterinary Healthcare Market By Product (Diagnostics, Therapeutics)
- Segmentation of France Veterinary Healthcare Market By Animal Type (Dogs and Cats, Horses, Poultry, Ruminants, Swine, Other Animals)
- Statistical Snap of France Veterinary Healthcare Market
- Expansion Analysis of France Veterinary Healthcare Market
- Problems and Obstacles in France Veterinary Healthcare Market
- Competitive Landscape in the France Veterinary Healthcare Market
- Impact of COVID-19 and Demonetization on France Veterinary Healthcare Market
- Details on Current Investment in France Veterinary Healthcare Market
- Competitive Analysis of France Veterinary Healthcare Market
- Prominent Players in the France Veterinary Healthcare Market
- SWOT Analysis of France Veterinary Healthcare Market
- France Veterinary Healthcare Market Future Outlook and Projections (FY’2023-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the France Veterinary Healthcare Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. France Veterinary Healthcare Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in France Veterinary Healthcare Market
7. France Veterinary Healthcare Market, By Product (USD Million)
7.1. France Veterinary Healthcare Market Value Share and Forecast, By Product, 2023-2033
7.2. Diagnostics
7.2.1. Clinical Chemistry
7.2.2. Diagnostic Imaging
7.2.3. Immunodiagnostic Tests
7.2.4. Molecular diagnostics
7.2.5. Other Diagnostics
7.3. Therapeutics
7.3.1. Vaccines
7.3.2. Parasiticides
7.3.3. Anti-infectives
7.3.4. Medical Feed Additives
7.3.5. Other Therapeutics
8. France Veterinary Healthcare Market, By Animal Type (USD Million)
8.1. France Veterinary Healthcare Market Value Share and Forecast, By Animal Type, 2023-2033
8.2. Dogs and Cats
8.3. Horses
8.4. Poultry
8.5. Ruminants
8.6. Swine
8.7. Other Animals
9. France Veterinary Healthcare Market Forecast, 2019-2033 (USD Million)
9.1. France Veterinary Healthcare Market Size and Market Share
10. France Veterinary Healthcare Market, By Product, 2019-2033 (USD Million)
10.1. France Veterinary Healthcare Market Size and Market Share By Product (2019-2026)
10.2. France Veterinary Healthcare Market Size and Market Share By Product (2027-2033)
11. France Veterinary Healthcare Market, By Animal Type, 2019-2033 (USD Million)
11.1. France Veterinary Healthcare Market Size and Market Share By Animal Type (2019-2026)
11.2. France Veterinary Healthcare Market Size and Market Share By Animal Type (2027-2033)
12. France Veterinary Healthcare Market, By Region, 2019-2033 (USD Million)
12.1. France Veterinary Healthcare Market Size and Market Share By Region (2019-2026)
12.2. France Veterinary Healthcare Market Size and Market Share By Region (2027-2033)
12.3. Central Region
12.4. Northern Region
12.5. Southern Region
13. Company Profile
13.1. Boehringer Ingelheim International GmbH
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Ceva Animal Health, Inc.
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Elanco
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. IDEXX Laboratories
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. Merck & Co. Inc.
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Vetoquinol
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Zoetis Inc.
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
